TABLE 1.
Demographic, clinical, and genetic data of HD patients (nine males and six females), presymptomatic subjects (seven males and three females), and healthy controls (16 males and nine females)
| Symptomatic HD patients (N = 15) | Presymptomatic HD subjects (N = 10) | Controls (N = 25) | |
|---|---|---|---|
| Age (yr) | 48.2 ± 10.2 (29–67) | 37.6 ± 6.7 (21–45) | 43.7 ± 10.6 (31–70) |
| CAG triplet number | 45.3 ± 3.2 (41–52) | 43.8 ± 2.5 (42–49) | – |
| Age at onset (yr) | 44.7 ± 10.9 (28–65) | – | – |
| Duration of illness (yr) | 3.9 ± 3.1 (1–10) | – | – |
| UHDRS part I | 31.0 ± 12.2 (17–53) | – | – |
| Total functional capacity | 10.7 ± 2.2 (6–13) | – | – |
Data are expressed as mean ± SD (range).